SR618

Lower channel breakout bounce.

Long
SR618 Updated   
NASDAQ:HRTX   Heron Therapeutics, Inc.
3
Low risk buy area. breaking out from lower regression channel w/divergence and volume. $15 will be some resistance, but after that could easily make it to $18.
Comment:
finding resistance from the 20 and 50 ma. if can break that then this thing could get a decent pop.
Comment:
seems that other sources say earnings are still in a week or so. so its looking good.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.